Bortezomib treatment causes remission in a Ph+ALL patient and reveals FoxO as a theranostic marker.
Cancer Biol Ther. 2011 Mar 15;11(6):552-8. doi: 10.4161/cbt.11.6.14675. Epub 2011 Mar 15.
Cancer Biol Ther. 2011.
PMID: 21282974
Free PMC article.